MTD - Mettler-Toledo International Inc.
NYSE
->
Healthcare
->
Diagnostics & Research
Columbus,
United States
Type: Equity
MTD price evolution
MTD
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $69.81 | $69.67 | $83.57 | $89.08 |
| Short term investments | ||||
| Net receivables | $663.89 | $634.97 | $648 | $640.05 |
| Inventory | $385.87 | $375.96 | $394.96 | $427.55 |
| Total current assets | $1230.2 | $1196.91 | $1246.51 | $1286.77 |
| Long term investments | ||||
| Property, plant & equipment | $803.37 | $763.21 | $780.72 | $780.01 |
| Goodwill & intangible assets | $955.54 | $947.84 | $959.69 | $961.88 |
| Total noncurrent assets | $2125.35 | $2091.82 | $2123.89 | $2123.14 |
| Total investments | ||||
| Total assets | $3355.55 | $3288.73 | $3370.39 | $3409.91 |
| Current liabilities | ||||
| Accounts payable | $210.41 | $173.97 | $170.23 | $176.73 |
| Deferred revenue | $202.02 | $190.78 | $204.55 | $211.3 |
| Short long term debt | $192.22 | $179.08 | $107.36 | $107.13 |
| Total current liabilities | $1181.08 | $1070.42 | $1008 | $1004.25 |
| Long term debt | $1888.62 | $1929.4 | $2045.46 | $2015.78 |
| Total noncurrent liabilities | $2324.41 | $2324.18 | $2452.1 | $2430.13 |
| Total debt | $2080.84 | $2108.48 | $2152.83 | $2122.91 |
| Total liabilities | $3505.49 | $3394.6 | $3460.1 | $3434.38 |
| Shareholders' equity | ||||
| Retained earnings | $7510.76 | $7328.29 | $7126.69 | $6912.77 |
| Other shareholder equity | -$319.81 | -$263.15 | -$267.22 | -$228.52 |
| Total shareholder equity | -$149.94 | -$105.87 | -$89.7 | -$24.47 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $69.81 | $95.97 | $98.56 | $94.25 |
| Short term investments | ||||
| Net receivables | $663.89 | $709.32 | $647.34 | $593.81 |
| Inventory | $385.87 | $441.69 | $414.54 | $297.61 |
| Total current assets | $1230.2 | $1375.09 | $1269.36 | $1056.9 |
| Long term investments | ||||
| Property, plant & equipment | $803.37 | $892.92 | $799.37 | $798.87 |
| Goodwill & intangible assets | $955.54 | $966.22 | $956.07 | $747.05 |
| Total noncurrent assets | $2125.35 | $2117.31 | $2057.44 | $1757.64 |
| Total investments | ||||
| Total assets | $3355.55 | $3492.39 | $3326.8 | $2814.55 |
| Current liabilities | ||||
| Accounts payable | $210.41 | $252.54 | $272.91 | $175.8 |
| Deferred revenue | $202.02 | $192.76 | $192.65 | $149.11 |
| Short long term debt | $192.22 | $106.05 | $101.13 | $50.32 |
| Total current liabilities | $1181.08 | $1147.73 | $1146.54 | $840.33 |
| Long term debt | $1888.62 | $1908.48 | $1580.81 | $1284.17 |
| Total noncurrent liabilities | $2324.41 | $2319.87 | $2008.84 | $1691.55 |
| Total debt | $2080.84 | $2014.53 | $1681.94 | $1334.49 |
| Total liabilities | $3505.49 | $3467.6 | $3155.38 | $2531.87 |
| Shareholders' equity | ||||
| Retained earnings | $7510.76 | $6726.87 | $5859.27 | $5095.6 |
| Other shareholder equity | -$319.81 | -$227.23 | -$255.22 | -$334.93 |
| Total shareholder equity | -$149.94 | $24.79 | $171.42 | $282.68 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $934.99 | $942.46 | $982.12 | $928.74 |
| Cost of revenue | $383.35 | $382.92 | $398.57 | $382.17 |
| Gross Profit | $551.64 | $559.54 | $583.54 | $546.57 |
| Operating activities | ||||
| Research & development | $46.44 | $46.13 | $47.24 | $45.48 |
| Selling, general & administrative | $223.43 | $217.45 | $228.59 | $234.64 |
| Total operating expenses | $303.57 | $288.1 | $300.89 | $301.77 |
| Operating income | $248.06 | $271.44 | $282.65 | $244.79 |
| Income from continuing operations | ||||
| EBIT | $252.21 | $271.44 | $282.65 | $244.79 |
| Income tax expense | $47.76 | $49.53 | $49.48 | $38.18 |
| Interest expense | $19.66 | $20.28 | $19.25 | $18.18 |
| Net income | ||||
| Net income | $184.79 | $201.63 | $213.93 | $188.43 |
| Income (for common shares) | $184.79 | $201.63 | $213.93 | $188.43 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $3788.31 | $3919.71 | $3717.93 | $3085.18 |
| Cost of revenue | $1547.02 | $1611.67 | $1546.38 | $1284.15 |
| Gross Profit | $2241.29 | $2308.04 | $2171.55 | $1801.03 |
| Operating activities | ||||
| Research & development | $185.28 | $177.12 | $169.77 | $140.1 |
| Selling, general & administrative | $904.11 | $938.46 | $943.98 | $820.22 |
| Total operating expenses | $1194.34 | $1191.38 | $1182.06 | $1027.5 |
| Operating income | $1046.95 | $1116.66 | $989.5 | $773.53 |
| Income from continuing operations | ||||
| EBIT | $1051.09 | $1125.98 | $992.6 | $787.36 |
| Income tax expense | $184.95 | $198.09 | $180.38 | $146 |
| Interest expense | $77.37 | $55.39 | $43.24 | $38.62 |
| Net income | ||||
| Net income | $788.78 | $872.5 | $768.99 | $602.74 |
| Income (for common shares) | $788.78 | $872.5 | $768.99 | $602.74 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $184.79 | $201.63 | $213.93 | $188.43 |
| Operating activities | ||||
| Depreciation | $30.62 | $30.5 | $30.24 | $29.8 |
| Business acquisitions & disposals | -$5.2 | -$0.61 | ||
| Stock-based compensation | $5.48 | $4.23 | $4.2 | $4.03 |
| Total cash flows from operations | $281.5 | $264.3 | $266.81 | $153.26 |
| Investing activities | ||||
| Capital expenditures | -$32.25 | -$20.7 | -$28.34 | -$23.2 |
| Investments | $6.09 | |||
| Total cash flows from investing | -$35.5 | -$30.89 | -$42.91 | -$22.39 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$176 | -$223.85 | -$242.39 | -$238.53 |
| Net borrowings | -$72.97 | -$19.45 | $20.69 | $101.5 |
| Total cash flows from financing | -$248.97 | -$245.55 | -$227.43 | -$137.63 |
| Effect of exchange rate | $3.1 | -$1.75 | -$1.98 | -$0.12 |
| Change in cash and equivalents | $0.13 | -$13.9 | -$5.51 | -$6.88 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $788.78 | $872.5 | $768.99 | $602.74 |
| Operating activities | ||||
| Depreciation | $121.16 | $113.02 | $108.06 | $98.71 |
| Business acquisitions & disposals | -$5.81 | -$37.95 | -$220.86 | -$6.24 |
| Stock-based compensation | $17.93 | $19.66 | $19.59 | $18.69 |
| Total cash flows from operations | $965.87 | $859.07 | $908.83 | $724.7 |
| Investing activities | ||||
| Capital expenditures | -$104.49 | -$120.84 | -$103.93 | -$89.39 |
| Investments | $6.09 | $29.67 | ||
| Total cash flows from investing | -$131.69 | -$139.4 | -$314.11 | -$100.36 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$880.77 | -$1066.78 | -$979.53 | -$748.28 |
| Net borrowings | $29.77 | $359.86 | $391.97 | $5.17 |
| Total cash flows from financing | -$859.59 | -$716.04 | -$590.55 | -$743.91 |
| Effect of exchange rate | -$0.75 | -$6.23 | $0.14 | $6.04 |
| Change in cash and equivalents | -$26.16 | -$2.6 | $4.31 | -$113.53 |
News
Fundamentals
| Market cap | $26.72B |
|---|---|
| Enterprise value | $28.73B |
| Shares outstanding | 21.53M |
| Revenue | $3.79B |
|---|---|
| EBITDA | $1.17B |
| EBIT | $1.05B |
| Net Income | $788.78M |
| Revenue Q/Q | -11.60% |
| Revenue Y/Y | -3.35% |
| P/E ratio | 33.88 |
|---|---|
| EV/Sales | 7.58 |
| EV/EBITDA | 24.51 |
| EV/EBIT | 27.34 |
| P/S ratio | 7.05 |
| P/B ratio | 157.30 |
| Book/Share | 7.89 |
| Cash/Share | 3.24 |
| EPS | $36.64 |
|---|---|
| ROA | 23.50% |
| ROE | -852.77% |
| Debt/Equity | -23.38 |
|---|---|
| Net debt/EBITDA | 2.93 |
| Current ratio | 1.04 |
| Quick ratio | 0.71 |